Volume 5, Issue 8: Using Real World Data to Individualize HCV Management

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 5, Issue 8)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Discuss the real-world data to support a sofosbuvirledipasvir treatment duration of 8 weeks versus 12 weeks.
  • Summarize the current hepatitis C treatment options for patients with advanced kidney disease.
  • Describe the risks and benefits of hepatitis C therapies in HIV-HCV coinfected patients.
 
 

 

Additional information
Contact email: 
Course summary
Available credit: 
  • 0.50 ANCC
  • 1.00 Attendance
Course opens: 
09/28/2017
Course expires: 
09/27/2019
Cost:
$0.00
Andrew J. Muir, MD
Professor of Medicine and Chief, Division of Gastroenterology
Buke University School of Medicine
Durham, North Carolina
 
 

Available Credit

  • 0.50 ANCC
  • 1.00 Attendance

Accreditation Period

Course opens: 
09/28/2017
Course expires: 
09/27/2019

Price

Cost:
$0.00
Please login or register to take this course.

Click HERE to be directed to the DKB website and proceed as instructed on the site. After completing the post-test and evaluation, DKB will award your certificate via email.